Explained
Content Types
Explained
1
Essays
3
DCVC Announcements
25
Q&A
12
Snapshot
3
Snapshot
Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells
Snapshot
CH4 Global set to launch world's first commercial scale Asparagopsis production facility
Snapshot
How Noetik uses images to give its AI model a deeper understanding of cancer
Company Profile
8
Company Profile
Why Kanvas built its own production line for microbiome therapeutics
Company Profile
Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy
Company Profile
Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits
Company Profile
Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners
News
118
News
Radiant raises $300 million+ Series D toward portable nuclear energy at scale
News
Mythic raises $125M to break through AI’s power wall
News
Fervo raises $462M to power the grid’s zero-carbon future
News
Relation unveils atopic diseases agreement with Novartis—$55 million up front and up to $1.7 billion in milestone-based payments; DCVC, NVIDIA NVentures, and Magnetic Ventures co-lead $26M fundraise
Thoughts
31
Deep Tech Opportunities Report
31
Deep Tech Opportunities Report
DCVC DTOR 2025: The increasing volatility of electrical supply and demand means it’s time to invest more in grid-stabilizing technologies
Deep Tech Opportunities Report
DCVC DTOR 2025: One way to stop adding carbon to the air is to get the carbon we need from the air
Deep Tech Opportunities Report
DCVC DTOR 2025: Skyrocketing electric demand requires deeper investments in carbon-free energy
Deep Tech Opportunities Report